Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity

Canadian Journal of Physiology and Pharmacology

Volumn 75, Issue 12, 1997, Pages 1356-1361

  Badary, Osama A ^a   Nagi, Mahmoud N ^a   Al Shabanah, Othman A ^a   Al Sawaf, Hussain A ^a   Al Sohaibani, Mohammed O ^b   Al Bekairi, Abdullah M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antitumor activity; Cisplatin; Nephrotoxicity; Thymoquinone

Indexed keywords

CISPLATIN; ESSENTIAL OIL; NIGELLA SATIVA EXTRACT; THYMOQUINONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; EHRLICH ASCITES TUMOR; FEMALE; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY MASS; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; UREA BLOOD LEVEL; URINE VOLUME;

EID: 0031431309     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y97-169     Document Type: Article

References (36)

1. Aboutabl, E.A., El-Azzouny, A.A., and Hammerschmidt, F.J. 1986. Aroma volatiles of Nigella saliva. 1. Seeds. In Progress in Essential Oil Research, Proceedings of the International Symposium on Essential Oils. Edited by E.J. Brunke. DeGruyter, Berlin, pp. 49-55.
2. Al-Gharably, N.M., Badary, O.A., Nagi, M.N., Al-Shabanah, O.A., Al-Sawaf, H.A., Al-Rikabi, A.C., and Al-Bekairi, A.M. 1997. Thymoquinone ameliorates carbon tetrachloride hepatotoxicity in mice. Res. Commun. Pharmacol. Toticol. 2: 41-50.
3. Al-Shabanah, O.A., Badary, O.A., Nagi, M.N., Al-Gharably, N.M., Al-Rikabi, A.C., and Al-Bekairi, A.M. 1997. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. J. Exp. Clin. Cancer Res. In press.
4. Badary, O.A., Moustafa, A.M., Abd El-Aziz, A.H., Hafez, Y., Salama, S.A., and Hamada, F.M. 1996. The effects of co-administration of cisplatin and L-histidinol on cisplatin-induced antitumor activity and toxicity in mice bearing Ehrlich ascites carcinoma. J. Egypt. Soc. Toxicol. 16: 5-9.
5. Badary, O.A., Nagi, M.N., Al-Sawaf, H.A., Al-Harbi, M., and Al-Bekairi, A.M. 1997. Effect of L-histidinol on cisplatin nephrotoxicity in the rat. Nephron, 77: 435-439.
6. Baldew, G.S., van der Hamer, C.A., Los, G., Vermeulen, N.B., deGoeij, J.M., and McVie, J.G. 1989. Selenium-induced protection against cis-diamminedichloroplatinum (II) nephrotoxicity in mice and rats. Cancer Res. 49: 3020-3023.
7. Bartels, H., Bohmer, M., and Heieri, C. 1972. Serum kreatinin bestimmung ohne enteiweissen. Clin. Chim. Acta, 37: 193-197.
8. Chakravarty, N. 1993. Inhibition of histamine release from mast cells by Nigellone. Ann. Allergy, 70: 237-247.
9. Daugaard, G., Abildgaard, U., Holstein-Rathlou, N.H., Bruunshuus, I., Bucher, D., and Leyssac, P.P. 1988. Renal tubular function in patients treated with high dose cisplatin. Clin. Pharmacol. Ther. 44: 164-172.
10. El-Tahir, K.E., Ashour, M.M., and Al-Harbi, M.M. 1993. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanisms of action. Gen. Pharmacol. 24: 1123-1131.
11. Gaedeke, J., Pels, L.M., Bokemeyer, C., Mengs, U., Stole, H., and Lentzen, H. 1996. Cisplatin nephrotoxicity and protection by silibinin. Nephrol. Dial. Transplant. 11: 55-62.
12. Geran, R.I., Greenberg, N.H., McDonald, M., Schumacher, A.M., and Abbott, B.J. 1972. Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother. Rep. 3: 1-103.
13. Hannemann, J., and Baumann, K. 1988. Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicology, 51: 119-132.
14. Heidemann, H.T., Muller, S., Mertins, L., Stepan, G., Hoffmann, K., and Ohnhaus, E.E. 1989. Effect of aminophylline on cisplatin nephrotoxicity in the rat. Br. J. Pharmacol. 97: 313-318.
15. Houghton, P.J., Zarka, R., de las Heras, B., and Hoult, J.R. 1995. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med. 61: 33-36.
16. Hutchinson, F.N., Ferez, E.A., Gandara, D.R., Lawrence, H.J., and Kayson, G.A. 1988. Renal salt wasting in patients treated with cisplatin. Ann. Intern. Med. 308: 21-25.
17. Ishikawa, M., Takayangi, Y., and Sasakiki, I. 1990. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice. Res. Commun. Chem. Pathol. Pharmacol. 67: 131-141.
18. 10propargyl-5,8-dideazafolic acid (CB3717) and a non-nephrotoxic analogue ICI D1694, in mice. Br. J. Cancer, 64: 833-838.
19. Loehrer, P.J., and Einhorn, L.H. 1984. Cisplatin. Ann. Intern. Med. 100: 704-713.
20. Lote, C.J., Harpur, E.S., Thewles, A., and Phipps, D.J. 1987. Renal response to vasopressin and indomethacin in cisplatin-treated rats. Clin. Sci. 73: 377-381.
21. McKeage, M.J., Morgan, S.E., Boxall, F.E., Murrer, B.A., Hard, G.C., and Harrap, K.R. 1993. Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents. Br. J. Cancer, 67: 996-1000.
22. Moel, D.I., Safirstein, R.L., Cohn, R.A., and Renning, J. 1987. The role of prostaglandins in early polyuria induced by cisplatin in the rat. Nephron, 46: 91-95.
23. Nair, S.C., Salomi, M.J., Pankkar, B., and Panikkar, K.R. 1991. Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in mice. J. Ethnopharmacol. 31: 75-83.
24. Patton, C.J., and Crouch, S.R. 1977. Spectrophotometric and kinetics investigation of the Berthelot reaction for the determination of ammonia. Anal. Chem. 49: 464-469.
25. Prestayko, A.W., Crooke, S.T., and Carter, S.K. 1980. Cisplatin: current status and new developments. Academic Press Inc., New York.
26. Sadzuka, Y., Shmizu, Y., Takino, Y., and Hirota, S. 1994. Protection against cisplatin-induced nephrotoxicity in the rat by inducers and an inhibitor of glutathione S-transferase. Biochem. Pharmacol. 48: 453-459.
27. Salomi, M.J., Nair, S.C., and Panikkar, K.R. 1991. Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutr. Cancer, 16: 67-72.
28. Salomi, N.J., Nair, S.C., Jayawardhanan, K.K., Varghese, C.D., and Panikkar, K.R. 1992. Antitumor principles from Nigella sativa seeds. Cancer Lett. 63: 41-46.
29. Somani, S.M., Ravi, R., and Rybak, L.P. 1995. Diethyldithiocarbamate protection against cisplatin nephrotoxicity: antioxidant system. Drug Chem. Toxicol. 18: 151-170.
30. Tay, L.K., Bregman, C.L., Masters, B.A., and Williams, P.D. 1988. Effect of cis-diamminedichloroplatinum on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture. Cancer Res. 48: 2538-2543.
31. Vermeulen, N., and Baldew, G.S. 1992. The role of lipid peroxidation in the nephrotoxicity of cisplatin. Biochem. Pharmacol. 44: 1139-1199.
32. von Hoff, D.D., Schilsky, R., Reichert, C.M., Reddick, R.L., Rozenweig, M., Young, R.C., and Muggia, F. 1979. Toxic effects of cisdichlorodiammine platinum in man. Cancer Treat. Rep. 63: 1527-1531.
33. Walker, E.M., and Gale, G.R. 1981. Methods of reduction of cisplatin nephrotoxicity. Ann. Clin. Lab. Sci. 11: 397-410.
34. Wong, N.L., Walker, V.R., Wong, E.F., and Sutton, R.A. 1993. Mechanism of polyuria after cisplatin therapy. Nephron, 65: 623-627.
35. Yamasaki, F., Ishibashi, M., Nakakuki, M., Watanabe, M., Shinkawa, T., and Mizota, M. 1996. Protective action of ulinastatin against cisplatin nephrotoxicity in mice and its effect on the lysosomal fragility. Nephron, 74: 158-167.
36. Zhang, J.G., and Lindup, E. 1993. Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices. Biochem. Pharmacol. 45: 2215-2222.